SCHEMBL12206187

SCHEMBL12206187

CC(C)c1ccccc1NC(=O)N1CCC[C@H]1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 3/20 0.58
▸ ITGB3 P05106 1/20 0.50
▸ ITGB1 P05556 1/20 0.50
▸ ITGAV P06756 1/20 0.50
▸ ITGA5 P08648 1/20 0.50
▸ ITGA4 P13612 1/20 0.50
▸ HDAC3 O15379 1/20 0.48
▸ HDAC1 Q13547 1/20 0.48
▸ HDAC2 Q92769 1/20 0.48
▸ ALDH1A1 P00352 4/20 0.48
▸ HPGD P15428 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ LMNA P02545 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ NAMPT P43490 1/20 0.45
▸ EPHX2 P34913 1/20 0.44
▸ MAPT P10636 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11718228 0.81 KDM4E (0.56) ITGB3ITGB1ITGAVITGA5ITGA4
SCHEMBL31234028 0.77 SMN1; SMN2 (0.67) ALDH1A1HPGDTSHRHSD17B10NAMPT
SCHEMBL8740407 0.74 ALDH1A1 (0.60) HDAC3HDAC1HDAC2ALDH1A1HPGD
SCHEMBL28943283 0.73 TRPV1 (0.70) TRPV1
SCHEMBL28943286 0.73 TRPV1 (0.70) TRPV1
Hydrochloric Acid SCHEMBL10715386 0.73 ALDH1A1 (0.59) HDAC3HDAC1HDAC2ALDH1A1HPGD
SCHEMBL11987478 0.72 KMT2A (0.66) TRPV1ALDH1A1TSHRLMNAL3MBTL1
SCHEMBL14291922 0.71 ALDH1A1 (0.50) ALDH1A1HPGDTSHRHSD17B10NAMPT
SCHEMBL15503309 0.71 ALDH1A1 (0.71) HDAC3HDAC1HDAC2ALDH1A1HPGD
SCHEMBL13753557 0.71 MEN1 (0.51) TRPV1ALDH1A1HPGDTSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380631-A1 Heteroaryl derivatives as DGAT1 inhibitors Novartis AG (CH) 2011-10-26 — — EP disclosed
Send feedback